Randomised, phase 1, dose-finding study of MEDI4166, a PCSK9 antibody and GLP-1 analogue fusion molecule, in overweight or obese patients with type 2 diabetes mellitus

Overview of attention for article published in Diabetologia, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

blogs: 1 blog

twitter: 18 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 83 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Gyrolab technology – a must-have in biotherapeutics development and manufacturing

Bioanalysis Zone, 03 Jul 2019

John Chappell – Application